Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enfuvirtide vs Nucleoside Regimens in Experienced HIV-1
NCT00100984Phase 4Terminated
- Sponsor
- Roche
- Start
- Jul 2004
- Primary completion
- Jul 2005
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enfuvirtide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Roche. Started Jul 2004; status: terminated.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00100984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100984.